1 – 10 of 74
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
- Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation
- 2013
- Suffering in silence: a qualitative study on the repercussions of having an adult child with cancer on the life of older parents
- Awareness of general practitioners concerning cancer patients' preferences for place of death: evidence from four European countries
- Resistance training in patients with radically treated respiratory cancer: a prospective randomized multi-center study (REINFORCE)
- The AYA box: a patient centered instrument in communication with adolescents and young adults with cancer and their care giving parents
- Temporal dynamics of the unfolded protein response and chemoresistance in hepatocellular carcinoma
- Adherence in elderly patients: the importance of adequate and continuous dosing
- Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: a randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
- Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052)
- 2012
- Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients